KEVIN PENO: Open Payments
NPI 1104430503 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 89 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $493 · 2025 $1,320
Food & beverage: $1,320
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $284 |
| ABBVIE INC. | 18 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $203 |
| E.R. Squibb & Sons, L.L.C. | 11 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Collegium Pharmaceutical, Inc. | 4 | $80 |
| Lundbeck LLC | 3 | $56 |
| Neurocrine BioSciences, Inc. | 3 | $51 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $49 |
| Alkermes, Inc. | 2 | $43 |
Products named: VRAYLAR, CAPLYTA, REXULTI, COBENFY, ABILIFY MAINTENA, TRINTELLIX, Jornay PM, INGREZZA.
Industry payments across PA — which companies pay providers there.
